Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotide analogues targeting human LMNA

Oligonucleotide analogues targeting human LMNA

US Patent 9682097 · Granted Jun 20, 2017

Estimated economic value: $44,806,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Exon skipping compositions for treating muscular dystrophy2024
Methods of installing fasteners and apparatus relating thereto2023
Oligonucleotide analogues targeting human LMNA2023
Oligonucleotide analogues targeting human LMNA2023
Exon skipping oligomer conjugates for muscular dystrophy2022
Processes for preparing oligomers2022
Compound and method for treating myotonic dystrophy2022
Antisense-induced exon2 inclusion in acid alpha-glucosidase2022
Oligonucleotide analogues targeting human LMNA2021
Oligonucleotide analogues targeting human LMNA2021
Antisense-induced exon exclusion in myostatin2021
Compound and method for treating myotonic dystrophy2021